Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.

Stem cells translational medicine - 1 Aug 2016

Braid Lorena R, Hu Wei-Gang, Davies John E, Nagata Les P

Abstract excerpt

UNLABELLED: : Mesenchymal stromal cells (MSCs) are being exploited as gene delivery vectors for various disease and injury therapies. We provide proof-of-concept that engineered MSCs can provide a useful, effective platform for protection against infectious disease. Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne pathogen affecting humans and equines and can be used in bio-warfare. No licensed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Half-Life

Share to Injections, Intramuscular

Share to Mesenchymal Stem Cells

Share to Protein Stability

Share to Umbilical Cord

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 27334491
DOI: 10.5966/sctm.2015-0341
PMCID: PMC4954456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.PMID 27334491Read ↗

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate ModelSemantic proximity Read ↗

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in MiceSemantic proximity Read ↗

Equine mesenchymal stem cell derived extracellular vesicle immunopathology biomarker discoverySemantic proximity Read ↗

IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in miceSemantic proximity Read ↗

Immune Reconstitution Prevents Continuous Equine Infectious Anemia Virus Replication in an Arabian Foal with Severe Combined Immunodeficiency: Lessons for Control of LentivirusesSemantic proximity Read ↗

Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.Semantic proximity Read ↗

Assessment in mice of vapA–DNA vaccination against Rhodococcus equi infectionSemantic proximity Read ↗

Engineered Vasculogenic Extracellular Vesicles Drive Nonviral Direct Conversions of Human Dermal Fibroblasts into Induced Endothelial Cells and Improve Wound ClosureSemantic proximity Read ↗

Modulation of immune responses in lentiviral vector-mediated gene transferSemantic proximity Read ↗

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxinSemantic proximity Read ↗

Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA VaccineSemantic proximity Read ↗

Production of extracellular vesicles from equine embryo-derived mesenchymal stromal cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.